For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
Cardlytics Inc (NASDAQ: CDLX) closed the day trading at $12.22 up 2.35% from the previous closing price of $11.94. In other words, the price has increased by $2.35 from its previous closing price. On the day, 0.83 million shares were traded. CDLX stock price reached its highest trading level at $12.22 during the session, while it also had its lowest trading level at $11.69.
Ratios:
For a better understanding of CDLX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.31 and its Current Ratio is at 1.31. In the meantime, Its Debt-to-Equity ratio is 1.97 whereas as Long-Term Debt/Eq ratio is at 1.96.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Craig Hallum on March 15, 2024, Upgraded its rating to Buy and sets its target price to $18 from $10 previously.
On November 29, 2023, Lake Street started tracking the stock assigning a Buy rating and target price of $13.
Wells Fargo Downgraded its Equal Weight to Underweight on September 08, 2022, whereas the target price for the stock was revised from $14 to $13.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 02 ’24 when Temsamani Karim Saad sold 32,564 shares for $13.69 per share. The transaction valued at 445,801 led to the insider holds 344,734 shares of the business.
Lynton Nicholas Hollmeyer sold 12,460 shares of CDLX for $170,620 on Apr 02 ’24. The Chief Legal & Privacy Officer now owns 71,355 shares after completing the transaction at $13.69 per share. On Apr 01 ’24, another insider, Temsamani Karim Saad, who serves as the Chief Executive Officer of the company, sold 154 shares for $14.41 each. As a result, the insider received 2,219 and left with 344,580 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDLX now has a Market Capitalization of 588686272 and an Enterprise Value of 713288256. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.74 while its Price-to-Book (P/B) ratio in mrq is 3.60. Its current Enterprise Value per Revenue stands at 2.307 whereas that against EBITDA is -19.17.
Stock Price History:
Over the past 52 weeks, CDLX has reached a high of $20.52, while it has fallen to a 52-week low of $4.94. The 50-Day Moving Average of the stock is 15.67%, while the 200-Day Moving Average is calculated to be 13.40%.
Shares Statistics:
Over the past 3-months, CDLX traded about 1.78M shares per day on average, while over the past 10 days, CDLX traded about 995200 shares per day. A total of 44.11M shares are outstanding, with a floating share count of 41.10M. Insiders hold about 6.83% of the company’s shares, while institutions hold 68.22% stake in the company. Shares short for CDLX as of 1711584000 were 5950753 with a Short Ratio of 3.34, compared to 1709164800 on 4355920. Therefore, it implies a Short% of Shares Outstanding of 5950753 and a Short% of Float of 15.359998999999998.
Earnings Estimates
The market rating for Cardlytics Inc (CDLX) is a result of the insights provided by Clorox Company (The) analysts actively involved in the assessment.The consensus estimate for the next quarter is $37.98, with high estimates of $0.68 and low estimates of $29.28.
